Research Paper Volume 15, Issue 14 pp 7098—7123
Comparative analyses of the prognosis, tumor immune microenvironment, and drug treatment response between left-sided and right-sided colon cancer by integrating scRNA-seq and bulk RNA-seq data
Figure 4. The relationship between the risk score of RCC prognostic model and clinical features, (A) M stage, (B) N stage, (C) Advanced pathological stages, (D) Microsatellite status, (E) T stage. The prognostic markers’ expression level in each cell types based on scRNA-seq dataset GSE200997, (F) RCC cells, (G) LCC cells. (H) Comparing the differences of markers’ expression between LCC and RCC samples based on TCGA-COAD cohort. Comparing the proportions of LCC and RCC patients in each CMS group on TCGA-COAD cohort (I) and GSE103479 (J). (K) Comparing the expression differences of markers among CMS groups based on TCGA-COAD cohort.